首页> 外文期刊>Journal of mass spectrometry: JMS >A high-throughput glutathione trapping assay with combined high sensitivity and specificity in high-resolution mass spectrometry by applying product ion extraction and data-dependent neutral loss
【24h】

A high-throughput glutathione trapping assay with combined high sensitivity and specificity in high-resolution mass spectrometry by applying product ion extraction and data-dependent neutral loss

机译:通过施加产品离子提取和数据依赖性中性损失,具有高敏感性谷胱甘肽诱捕测定,高分辨率质谱和高分辨率质谱和特异性

获取原文
获取原文并翻译 | 示例
           

摘要

Reactive metabolites are thought to play a pivotal role in the pathogenesis of some drug-induced liver injury (DILI) and idiosyncratic adverse drug reactions (IADRs), which is of concern to patient safety and has been a cause of drugs being withdrawn from the market place. To identify drugs with a lower propensity for causing DILI and/or IADRs, high-throughput assays to capture reactive metabolites are required in pharmaceutical industry for early drug discovery risk assessment. We describe the development of an assay to detect glutathione adducts with combined high sensitivity, enhanced specificity, and rapid data analysis. In this assay, compounds were incubated with human liver microsomes and a mixture of 1:1 of GSH (gamma-GluCysGly): GSX(gamma-GluCysGly-(C2N)-C-13-N-15) in a 96-well plate format. UPLC-UV and LTQ Orbitrap XL were employed to detect GSH-adducts using the following mass spectrometry setups: (a) selected ion monitoring (SIM) at m/z of 274 +/- 3 Da in negative mode with in-source fragmentation (SCID), which enables simultaneously monitoring two characteristic product ions of m/z 272.0888 (gamma-glutamyl-dehydroalanyl-glycine) and 275.0926 (gamma-glutamyl-dehydroalanyl-glycine-(C2N)-C-13-N-15); (b) full scan mode for acquisition of exact mass of glutathione adducts; (c) data-dependent MS2 scan through isotopic matching (M:M + 3.00375 = 1:1) for monitoring neutral loss fragments (144 Da from dehydroalanyl-glycine) and for structural information of glutathione adducts. This approach was qualified using eight compounds known to form GSH conjugates as reported in the literature. The high sensitivity and specificity were demonstrated in identifying unique CysGly adducts in the case of clozapine, diclofenac, and raloxifene and in identifying GSH-adducts of fragmented parent molecules in the case of amodiaquine and troglitazone. In addition, LC-UV chromatograms in the presence or absence of GSH/GSX allowed for identification of the rearranged glutathione add
机译:被认为在某种药物诱导的肝损伤(DiRi)和特质不良药物(IADRS)的发病机制中发挥关键作用,这对患者安全有所关注,并且是从市场中退出的药物的原因地方。为了识别具有较低倾向的药物,用于引起稀米和/或IADRS,在制药工业中需要高通量测定以捕获反应性代谢物,以进行早期药物发现风险评估。我们描述了检测谷胱甘肽加合物,以综合高灵敏度,增强的特异性和快速数据分析进行谷胱甘肽加合物的发展。在该测定中,将化合物与人肝微粒体温育,1:1的混合物(γ-葡糖果):GSX(γ-葡糖浆 - (C2N)-C-13-N-15)中的96孔板格式。采用UPLC-UV和LTQ orbitrap XL来使用以下质谱设定使用以下质谱设定:(a)在源自碎片中的负模式下的m / z的所选离子监测(SIM)(a) SCID),其同时监测M / Z 272.0888(γ-谷氨酰胺 - 脱氢氨基甲酰基 - 甘氨酸)和275.0926(γ-谷氨酰胺 - 脱氢甲醛 - 甘氨酸 - (C2N)-C-13-N-15)的两个特征产物离子; (b)用于采集精确质量的谷胱甘肽加合物的全扫描模式; (c)通过同位素匹配(M:M + 3.00375 = 1:1)进行数据依赖性MS2扫描,用于监测中性损失片段(来自脱氢甲醛 - 甘氨酸的144Da)和谷胱甘肽加合物的结构信息。这种方法使用已知的八种化合物来符合文献中报道的GSH缀合物。在氯氮平,双氯芬酸和雷洛昔芬的情况下鉴定独特的综合加合物以及鉴定碎裂的母体分子的GSH加合物,证明了高敏感性和特异性。此外,GSH / GSX存在或不存在的LC-UV色谱图允许鉴定重排谷胱甘肽添加

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号